Variant report
Variant | esv3373370 |
---|---|
Chromosome Location | chr9:12544154-12544615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180889749 | chr9:12544163-12544164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73649621 | chr9:12544199-12544200 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs576011418 | chr9:12544252-12544253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143154130 | chr9:12544264-12544265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555112781 | chr9:12544291-12544292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138913174 | chr9:12544294-12544295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540960832 | chr9:12544298-12544299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564201828 | chr9:12544303-12544304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531653548 | chr9:12544324-12544325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373078989 | chr9:12544351-12544352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142923031 | chr9:12544359-12544360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78852439 | chr9:12544368-12544369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563009602 | chr9:12544393-12544394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531792950 | chr9:12544469-12544470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553177174 | chr9:12544476-12544477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548823675 | chr9:12544504-12544505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183519005 | chr9:12544505-12544506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527873940 | chr9:12544507-12544508 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548100033 | chr9:12544548-12544549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs118009296 | chr9:12544549-12544550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369286196 | chr9:12544570-12544571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561710657 | chr9:12544591-12544592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200307629 | chr9:12544592-12544593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1325140 | chr9:12544593-12544594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549461622 | chr9:12544594-12544595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1325141 | chr9:12544595-12544596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77522227 | chr9:12544597-12544598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12540200-12544600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr9:12544400-12544600 | Enhancers | Brain Germinal Matrix | brain |
3 | chr9:12544600-12546400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |